[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Letters
November 11, 1998

Evidence Influencing British Health Authorities' Decisions in Purchasing Complementary Medicine

Author Affiliations
 

Margaret A.WinkerMD, Senior EditorIndividualAuthorPhil B.FontanarosaMD, Senior EditorIndividualAuthor

JAMA. 1998;280(18):1564-1565. doi:10-1001/pubs.JAMA-ISSN-0098-7484-280-18-jbk1111

To the Editor.— The Royal London Homoeopathic Hospital NHS Trust (RLHH), to our knowledge the only independent, public-sector hospital dedicated to complementary medicine (CM) in Europe, is committed to the evidence-based practice of CM.1 The RLHH operates within the National Health Service in a system in which health authorities, led by a director of public health (DPH) and, increasingly, by primary care groups responsible for smaller populations, make health care purchasing decisions and negotiate service contracts with secondary health care institutions.

First Page Preview View Large
First page PDF preview
First page PDF preview
×